Evidence map›Paper›PMID 29083055›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2018

Hormonal Regulation of Osteocyte Perilacunar and Canalicular Remodeling in the Hyp Mouse Model of X-Linked Hypophosphatemia.

Danielle Tokarz, Janaina S Martins, Elizabeth T Petit, Charles P Lin, Marie B Demay, Eva S Liu

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. The role of GDF5 in regulating enthesopathy development in the Hyp mouse model of XLH.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Conductive Hearing Loss in the Hyp Mouse Model of X-Linked Hypophosphatemia Is Accompanied by Hypomineralization of the Auditory Ossicles.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article
  16. Effects of Active Vitamin D or FGF23 Antibody onJournal of dental research · 2021
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Danielle TokarzAdvanced Microscopy Program, Center for Systems Biology and Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA.
Janaina S MartinsHarvard Medical School, Boston, MA, USA.
Elizabeth T PetitEndocrine Unit, Massachusetts General Hospital, Boston, MA, USA.
Charles P LinAdvanced Microscopy Program, Center for Systems Biology and Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA.
Marie B DemayHarvard Medical School, Boston, MA, USA.
Eva S LiuHarvard Medical School, Boston, MA, USA.
Massachusetts General Hospital · USHarvard University · US

Funding

Multi-wavelength femtosecond laser sources for intravital multiphoton microscopyR01EB017274 · NIBIB · CORNELL UNIVERSITY · PI LIN, CHARLES P., XU, CHRIS · 2013 to 2016
$2.6M
Etiology and Therapy of Rickets in the Hyp mouse model of XLHR01AR061376 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI DEMAY, MARIE · 2011 to 2015
$1.9M
Molecular and cellular determinants of enthesopathy in X-linked hypophosphatemiaK08AR067854 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI LIU, EVA S. · 2015 to 2019
$699k
NIAMS NIH HHS K08 AR067854NIAMS NIH HHS R01 AR061376NIBIB NIH HHS R01 EB017274
6 · The paper itself

Abstract

Osteocytes remodel their surrounding perilacunar matrix and canalicular network to maintain skeletal homeostasis. Perilacunar/canalicular remodeling is also thought to play a role in determining bone quality. X-linked hypophosphatemia (XLH) is characterized by elevated serum fibroblast growth factor 23 (FGF23) levels, resulting in hypophosphatemia and decreased production of 1,25 dihydroxyvitamin D (1,25D). In addition to rickets and osteomalacia, long bones from mice with XLH (Hyp) have impaired whole-bone biomechanical integrity accompanied by increased osteocyte apoptosis. To address whether perilacunar/canalicular remodeling is altered in Hyp mice, histomorphometric analyses of tibia and 3D intravital microscopic analyses of calvaria were performed. These studies demonstrate that Hyp mice have larger osteocyte lacunae in both the tibia and calvaria, accompanied by enhanced osteocyte mRNA and protein expression of matrix metalloproteinase 13 (MMP13) and genes classically used by osteoclasts to resorb bone, such as cathepsin K (CTSK). Hyp mice also exhibit impaired canalicular organization, with a decrease in number and branching of canaliculi extending from tibial and calvarial lacunae. To determine whether improving mineral ion and hormone homeostasis attenuates the lacunocanalicular phenotype, Hyp mice were treated with 1,25D or FGF23 blocking antibody (FGF23Ab). Both therapies were shown to decrease osteocyte lacunar size and to improve canalicular organization in tibia and calvaria. 1,25D treatment of Hyp mice normalizes osteocyte expression of MMP13 and classic osteoclast markers, while FGF23Ab decreases expression of MMP13 and selected osteoclast markers. Taken together, these studies point to regulation of perilacunar/canalicular remodeling by physiologic stimuli including hypophosphatemia and 1,25D. © 2017 American Society for Bone and Mineral Research.

Indexed as

AnimalsAntibodiesBiomarkersBone RemodelingCalcitriolCortical BoneDisease Models, AnimalFamilial Hypophosphatemic RicketsFibroblast Growth Factor-23Fibroblast Growth FactorsHormonesMice, Inbred C57BLOsteocytesSkullTibiaAntibodiesBiomarkersCalcitriolFgf23 protein, mouseFibroblast Growth Factor-23Fibroblast Growth FactorsHormonesBONE HISTOMORPHOMETRYBONE REMODELINGOSTEOCYTESOSTEOMALACIA AND RICKETSPTH/VIT D/FGF23

Identifiers

PMID29083055
PMCPMC6005377
OpenAlexW2769592366

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.